Towards a need to a “biological Sokal risk” in the era of tyrosine kinase inhibitors in choosing front-line therapy in chronic myeloid leukemia
| Image |  |
|---|---|
| Description | scientific article published on April 12, 2012 |
| Author/s | |
| Publication date | April 12, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://api.elsevier.com/content/article/PII:S0145212612001397?httpAccept=text/xml |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |